Opgen Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy OPGN

*Your capital is at risk

$24.75

+0 (+0%)

At Close: Jun 02, 2026

OpGen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 77.75. In total, the insiders bought 28.08M and sold 6.43M OPGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	77.75
● Buy	28.08M shares
● Sell	6.43M shares
92% Buy Activity Negligible or No Correlation
Buy Signal High Confidence Jun 01, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 77.75. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (92% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 05, 2024 Buy	Common Stock P-Purchase	Aei Capital Ltd 10 Percent Owner	10% Owner	1 800 000 Value: $1,643.9B
Aug 05, 2024 Sell	Common Stock S-Sale	Aei Capital Ltd 10 Percent Owner	10% Owner	1 800 000 Value: $1,643.9B
Aug 05, 2024 Sell	Common Stock S-Sale	Aei Capital Ltd 10 Percent Owner	10% Owner	1 800 000 Value: $1,643.9B
Jul 30, 2024 Buy	Common Stock	Aei Capital Ltd 10 Percent Owner	10% Owner	0 Value: $0
Jul 30, 2024 Buy	Series E Convertible Preferred Stock	Aei Capital Ltd 10 Percent Owner	10% Owner	263 961 Value: $799.8K
Jul 30, 2024 Buy	Series E Convertible Preferred Stock	Aei Capital Ltd 10 Percent Owner	10% Owner	263 961 Value: $799.8K
Jul 30, 2024 Buy	Common Stock	Aei Capital Ltd 10 Percent Owner	10% Owner	0 Value: $0
Jul 30, 2024 Sell	Series E Convertible Preferred Stock S-Sale	Lazar David E. Chief Executive Officer	CEO / President	550 000 Value: $0
Jul 30, 2024 Sell	Series E Convertible Preferred Stock S-Sale	Lazar David E. Chief Executive Officer	CEO / President	550 000 Value: $0
Apr 23, 2024 Buy	Series E Convertible Preferred Stock A-Award	Lazar David E. Chief Executive Officer	CEO / President	150 000 Value: $0
Apr 23, 2024 Buy	Series E Convertible Preferred Stock A-Award	Lazar David E. Chief Executive Officer	CEO / President	150 000 Value: $0
Apr 23, 2024 Buy	Series E Convertible Preferred Stock P-Purchase	Lazar David E. Chief Executive Officer	CEO / President	150 000 Value: $0
Apr 23, 2024 Buy	Series E Convertible Preferred Stock P-Purchase	Lazar David E. Chief Executive Officer	CEO / President	150 000 Value: $0
Apr 11, 2024 Buy	Common Stock A-Award	Ben-tzvi Avraham Director	Director	100 000 Value: $0
Apr 11, 2024 Buy	Common Stock A-Award	Ben-tzvi Avraham Director	Director	100 000 Value: $0
Apr 11, 2024 Buy	Common Stock A-Award	Natan David Director	Director	100 000 Value: $0
Apr 11, 2024 Buy	Common Stock A-Award	Mcmurdo Matthew Charles Director	Director	100 000 Value: $0
Apr 11, 2024 Buy	Common Stock A-Award	Lazar David E. Chief Executive Officer	CEO / President	100 000 Value: $0
Apr 11, 2024 Buy	Common Stock A-Award	Lazar David E. Chief Executive Officer	CEO / President	100 000 Value: $0
Apr 11, 2024 Buy	Common Stock A-Award	Mcmurdo Matthew Charles Director	Director	100 000 Value: $0
Apr 11, 2024 Buy	Common Stock A-Award	Natan David Director	Director	100 000 Value: $0
Apr 05, 2024 Buy	Series E Convertible Preferred Stock A-Award	Lazar David E. Chief Executive Officer	CEO / President	200 000 Value: $0
Apr 05, 2024 Buy	Series E Convertible Preferred Stock A-Award	Lazar David E. Chief Executive Officer	CEO / President	200 000 Value: $0
Apr 05, 2024 Buy	Series E Convertible Preferred Stock P-Purchase	Lazar David E. Chief Executive Officer	CEO / President	200 000 Value: $0
Apr 05, 2024 Buy	Series E Convertible Preferred Stock P-Purchase	Lazar David E. Chief Executive Officer	CEO / President	200 000 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT OPGEN, INC.

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis...

Read Full Profile Here